KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Change in Inventory (2016 - 2025)

NovoCure's Change in Inventory history spans 12 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 157.76% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $5.7 million, up 320.72%, while the annual FY2025 figure was $5.7 million, 320.72% up from the prior year.
  • Change in Inventory for Q4 2025 was $2.0 million at NovoCure, up from -$886000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $4.8 million in Q1 2022 and bottomed at -$3.8 million in Q3 2021.
  • The 5-year median for Change in Inventory is $982500.0 (2021), against an average of $693900.0.
  • The largest annual shift saw Change in Inventory plummeted 7041.82% in 2021 before it surged 594.74% in 2023.
  • A 5-year view of Change in Inventory shows it stood at $1.7 million in 2021, then soared by 34.02% to $2.3 million in 2022, then crashed by 70.67% to $669000.0 in 2023, then crashed by 613.45% to -$3.4 million in 2024, then skyrocketed by 157.76% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Change in Inventory are $2.0 million (Q4 2025), -$886000.0 (Q3 2025), and $629000.0 (Q2 2025).